Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07794683Phase 1Not yet recruiting
Phase 1, randomised, double-blind trial of KM04 in infertility (3 arms), sponsored by Xentria. Primary endpoints: Maximum observed serum concentration and Area under the concentration-time curve from time 0 to the last quantifiable concentration. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07794683.